SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Brink Mikael) srt2:(2010-2014)"

Sökning: WFRF:(Brink Mikael) > (2010-2014)

  • Resultat 1-10 av 21
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Bokarewa, Maria, 1963, et al. (författare)
  • Survivin but not Fms-like tyrosine kinase 3 ligand is up-regulated before the onset of rheumatoid arthritis: a pilot study.
  • 2014
  • Ingår i: Arthritis research & therapy. - : Springer Science and Business Media LLC. - 1478-6362 .- 1478-6354. ; 16:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Antibodies against citrullinated peptides (anti-CCP) and increased levels of cytokines precede the development of rheumatoid arthritis (RA) by several years. Recently, the proteins survivin and Fms-like tyrosine kinase 3 ligand (Flt3L) have been identified as biomarkers of RA associated with joint destruction. Our objective was to investigate the potential of survivin and Flt3L as predictors of RA in samples from patients prior to onset of symptoms.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  • Brink, Mikael, et al. (författare)
  • Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis
  • 2013
  • Ingår i: Arthritis and Rheumatism. - : Wiley. - 0004-3591 .- 1529-0131. ; 65:4, s. 899-910
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective The presence of antibodies against cyclic citrullinated peptides has been demonstrated to precede the onset of symptoms of rheumatoid arthritis (RA) by several years. The aim of this study was to analyze antibodies against 10 citrullinated autoantigen-derived peptides for reactivity before the onset of RA symptoms. Methods A casecontrol study was conducted within the Medical Biobank of Northern Sweden. The study was performed in 409 individuals, 386 of whom donated 717 blood samples before the onset of symptoms of RA (pre-patients). The median period of time predating the onset of RA was 7.4 years. A total of 1,305 population-based control subjects were also studied. Antibodies to 10 citrullinated peptides, fibrinogen 573 (Fib573), Fib591, Fib3652, Fib72, Fib74, -enolase (citrullinated -enolase peptide 1 [CEP-1]), triple-helical type II collagen peptide C1 (citC1III), filaggrin, vimentin 217 (Vim217), and Vim6075, were analyzed using a microarray system. Results The fluorescence intensity of antibodies against Fib3652, Fib74, CEP-1, citC1III, and filaggrin was significantly increased in pre-patients compared with controls (P < 0.001). The levels of the earliest-detectable antibodies (Fib591 and Vim6075) fluctuated over time, with only a slight increase after the onset of disease. The frequency of antibodies against Fib3652, CEP-1, and filaggrin increased gradually, reaching the highest levels before symptom onset. The frequency of a cluster of antibodies, citC1III, Fib573, and Fib74, increased only slightly before the onset of symptoms but increased prominently after disease onset. The odds ratio for the development of RA in individuals expressing both CEP-1 and Fib3652 antibodies (using data from samples obtained <3.35 years predating symptom onset) was 40.4 (95% confidence interval 19.882.3) compared with having either antibody alone. Conclusion Development of an immune response toward citrullinated peptides is initially restricted but expands with time to induce a more specific response, with levels, particularly those of antibodies against CEP-1, Fib3652, and filaggrin, increasing during the predating time period closer to the onset of symptoms.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 21
Typ av publikation
tidskriftsartikel (20)
rapport (1)
Typ av innehåll
övrigt vetenskapligt/konstnärligt (10)
refereegranskat (10)
populärvet., debatt m.m. (1)
Författare/redaktör
Rönnelid, Johan (9)
Rantapää-Dahlqvist, ... (9)
Klareskog, Lars (6)
Hansson, Monika (6)
Rantapää-Dahlqvist, ... (6)
Holmdahl, Rikard (4)
visa fler...
Mathsson, Linda (4)
Jakobsson, Per-Johan (4)
KLARESKOG, L (3)
Verheul, M K (2)
Bakkman, Linda (2)
Ekblom, Björn (2)
Lejon, Kristina (2)
Enqvist, Jonas K (2)
Mattsson, C. Mikael (2)
Stenlund, Hans (1)
Holmdahl, R (1)
Bokarewa, Maria, 196 ... (1)
Jonsson, Magnus, 196 ... (1)
Pettersson, Håkan, 1 ... (1)
Hallmans, Göran (1)
Trouw, L A (1)
Toes, R. E M (1)
Hu, Xiao-Lei (1)
Erlandsson, Malin, 1 ... (1)
Sahlén, Göran, 1964- (1)
Dahlqvist, Per (1)
Rögnvaldsson, Thorst ... (1)
Holmgren, Noél (1)
Svensson, Bertil, 19 ... (1)
Gustafsson, Linnea, ... (1)
Alexandersson, Mikae ... (1)
Nilsson, Pernilla, 1 ... (1)
Rundquist, Jonas, 19 ... (1)
Benner, Mats (1)
Hållander, Magnus, 1 ... (1)
Rosén, Bengt - Göran ... (1)
Erlandsson, M. (1)
Bokarewa, M. (1)
Lutz, Mareike, 1967- (1)
Florén, Henrik, 1972 ... (1)
Werner, Sven, 1952- (1)
Nygren, Jens, 1976- (1)
Rantapää-Dahlqvist, ... (1)
Lassen, Ewa (1)
Mattsson, Marie, 196 ... (1)
Hoveskog, Maya, 1980 ... (1)
Fleischer, Siegfried ... (1)
Berg, Martin, 1977- (1)
Kokkonen, Heidi (1)
visa färre...
Lärosäte
Umeå universitet (17)
Karolinska Institutet (10)
Uppsala universitet (9)
Gymnastik- och idrottshögskolan (2)
Göteborgs universitet (1)
Högskolan i Halmstad (1)
visa fler...
Mittuniversitetet (1)
visa färre...
Språk
Engelska (21)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (19)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy